Teriparatide acetate

Anti-TERF2 telomeric repeat binding factor 2, 100ul UN 1687

Anti-TERF2 telomeric repeat binding factor 2, 25ul UN 1687 6

InformationApalutamide (ARN-509) Apalutamide (ARN-509) is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate cancer treatment. Phase 3.In vitroARN-509 (&lt: 10 μM) inhibits

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer (extracted from

ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of

ARD-266 is a highly potent and von Hippel-Lindau E3 ligase-based Androgen Receptor ( AR ) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR -positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC 50 values of

ARD-69 (compound 34) is a potent PROTAC androgen receptor degrader. ARD-69 induces degradation of androgen receptor (AR) protein in AR-positive prostate cancer cell lines. ARD-69 suppresses AR-regulated gene expressionForm:SolidIC50&amp:

ASP6432 is a potent and selective type 1 lysophosphatidic acid receptor (LPA1) antagonist with IC 50 s of 11 nM and 30 nM for human LPA1 and rat LPA1, respectivelyIn VitroASP6432 inhibits the LPA-induced proliferation of human prostate stromal

ASP6432 is a potent and selective type 1 lysophosphatidic acid receptor (LPA1) antagonist with IC 50 s of 11 nM and 30 nM for human LPA1 and rat LPA1, respectivelyIn VitroASP6432 inhibits the LPA-induced proliferation of human prostate stromal